Adverum Biotechnologies Gene Therapy 2016

Adverum Biotechnologies presented its gene therapy platform and development strategy, highlighting its AAV vector technology, manufacturing capabilities, and strategic partnerships with Regeneron and Editas. The company emphasized its strong cash position and extensive patent portfolio supporting its clinical pipeline with clear unmet medical needs.</description> <parameter name="content_type">investor_presentation